News

The cell-by-cell atlas will help in the study of eye disorders and development of cell therapy to replace damaged eye tissue.

In order to improve the biomanufacturing process of advanced cell-based therapies, a team of researchers has developed a dynamic sampling platform that provides a real time analysis of cells as they are modified and grown.

An international team of scientists believe they may have found a molecular mechanism behind the extremely rare blood clots linked to adenovirus COVID-19 vaccines.

In the first head-to-head comparison of the effectiveness of the Pfizer-BioNTech and Moderna COVID-19 vaccines, researchers have found that the Moderna vaccine offered an increased level of protection.

According to a new study, an important player in the healthy development of female embryos turns out also to play a key role in regulating the behavior of chromosome loops and gene expression in both sexes.

Things that are freeze-dried: Astronaut food. Emergency rations. And, just maybe, some future COVID-19 vaccines.

Researchers have developed a molecule of pharmaceutical interest from a protein found in rattlesnake venom. The molecule, now called PEG-rCollinein-1, is a possible drug candidate to modulate blood clotting.

Researchers found that the same type of antibody can neutralize Zika and dengue viruses in two different ways — one where it binds to the virus and deactivates it, which is the traditional way we think about antibody activity, and the other where it burrows in and distorts the virus.

The method produces genetically corrected autologous pluripotent stem cells from a 2-3 mm skin biopsy from patients with different genetic diseases. The corrected stem cells are essential in the research and for the development of new therapies for the diseases in question.

It’s hard to imagine viruses as something other than hostile enemies to be vanquished, but in a recent review article, researchers describe a class of viruses that act to combat rather than cause deadly disease.